Fosun Pharma definition
Examples of Fosun Pharma in a sentence
BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer.
As at the date of this announcement, Jiangsu Fosun is a wholly-owned subsidiary of Fosun Pharma (a controlling shareholder of the Company), therefore, Jiangsu Fosun is a connected person of the Company by virtue of being an associate of the Company’s controlling shareholder.
Fosun Pharma is a joint stock company established in the PRC, the H shares and A shares of which are listed and traded on the Main Board of the Stock Exchange (stock code: 02196) and the Shanghai Stock Exchange (stock code: 600196), respectively.
Jiangsu Fosun is a company established in the PRC and a wholly owned subsidiary of Fosun Pharma.
Therefore, Fosun Pharma Industrial Development is a connected person of the Company by virtue of being an associate of the Company’s controlling shareholder.
Ahon Pharma joined Shanghai Fosun Pharma Group Company in 2011 and is one of Fosun Pharma’s core member enterprises.
As at the date of this announcement, Fosun Pharma Industrial Development is a wholly-owned subsidiary of Fosun Pharma, the controlling shareholder of the Company.
Fosun Pharma maintains a national recognized enterprise technology center and a highly capable international R&D team, with relentless efforts exerted on innovation and research of therapeutic areas including cardiovascular system, central nervous system, blood system, metabolism and alimentary system, anti-infection and anti-tumor.
Mr. ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ is the Chief Executive Officer of the Company, which is a subsidiary of Fosun Pharma.
As the highest applicable percentage ratio in respect of the annual caps for the transactions with Fosun Pharma Industrial Development under the Clinical Trial Research Services Agreement is more than 0.1% but less than 5%, the transactions under the Clinical Trial Research Services Agreement are subject to the reporting and announcement requirements but are exempt from the independent shareholders’ approval requirement under Chapter 14A of the Listing Rules.